Portfolio · 19 companies
8 Exits · Active fund
Companies
making it happen
Capital-efficient B2B SaaS and tech-enabled services start-ups partnering with us to scale rapidly within Pharma Tech.
Our earlier funds backed capital-efficient healthcare software companies across provider, payer, and pharma markets. Fund III is focused exclusively on Pharma Tech and tech-enabled pharma services.


















